Issue 2, 2021

In silico strategy for isoform-selective 5-HT2AR and 5-HT2CR inhibitors

Abstract

5-HT2AR and 5-HT2CR are widely expressed throughout the brain and have been drawing significant clinical interest due to their involvement in mediating mental disorders. Indeed, 5-HT2AR acts as a biological target for atypical antipsychotics and addiction, and 5-HT2CR also serves as a therapeutic target for depression and addiction. Given that 5-HT2AR and 5-HT2CR provide opposing influences upon DA mesocorticoaccumbens output, plus 5-HT2CR is thought to be involved in appetite that might result in the side effect of weight gain, it makes great sense for drug design to provide the selective mechanisms of 5-HT2AR and 5-HT2CR in order to meet the increasing need for more effective medications. Toward this end, the structure and chemical properties of crucial residues between 5-HT2AR and 5-HT2CR were analyzed based on their individual crystal structures. Moreover, pruvanserin and RS102221, the highly selective antagonists of 5-HT2AR and 5-HT2CR, respectively, were employed to illuminate the selective binding modes through a comprehensive application of in silico methods, including molecular docking, molecular dynamic simulations, MM-GBSA, alanine scanning mutagenesis, DFT technologies, and structure-based pharmacophore modeling. It was found that although 5-HT2A/CR isoforms share high sequence homology in active pockets, they do possess distinctive physiological functions. The key residues that contributed to the selectivity between 5-HT2A/CR are ASP155, LEU229, TRP336, and PHE340 of 5-HT2AR, as well as ASP134, LEU209, and PHE328 of 5-HT2CR. Moreover, in view of the much smaller hydrophobic region of the 5-HT2AR, a ligand with reduced side chain volume would increase its selectivity to 5-HT2AR, and vice versa. In addition, considering that RS102221/5-HT2CR formed more water bridges compared to that of pruvanserin/5-HT2AR, hydrogen bonding interactions should be emphasized in the design of 5-HT2CR selective inhibitors. Collectively, this study provided novel insights into the rational selectivity mechanisms of 5-HT2AR/5-HT2CR inhibitors, which laid important foundations for designing selective inhibitors towards 5-HT2AR and 5-HT2CR.

Graphical abstract: In silico strategy for isoform-selective 5-HT2AR and 5-HT2CR inhibitors

Supplementary files

Article information

Article type
Paper
Submitted
26 Sep 2020
Accepted
07 Jan 2021
First published
07 Jan 2021

Mol. Syst. Des. Eng., 2021,6, 139-155

In silico strategy for isoform-selective 5-HT2AR and 5-HT2CR inhibitors

X. Geng, Y. Wang, H. Wang, B. Hu, J. Huang, Y. Wu, J. Wang and F. Zhang, Mol. Syst. Des. Eng., 2021, 6, 139 DOI: 10.1039/D0ME00137F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements